Effectiveness and Safety of Splenic Micro-wave Ablation Combined with Hepatic Ar-terial Chemoembolization for Hepatocellular Carcinoma Associated with Hypersplenism: A Prospective Study in 5 Patients

Guobao Wang¹, Fujun Zhang², Sheng Peng², Tao Zhang², Mingjian Lu², Yangkui Gu², Jinhua Huang², Fei Gao^2*

¹Department of Endoscopy and Laser, Sun Yat-Sen University Cancer Center and State Key Laboratory of Oncology in South China, Guangzhou, China.
²Department of Interventional Radiology, Sun Yat-Sen University Cancer Center and State Key Laboratory of Oncology in South China, Guangzhou, China.

DOI: 10.4236/ojrad.2015.52012                

Abstract

The aim was to prospectively evaluate the efficacy and safety of splenic microwave ablation (MWA) combined with transcatheter hepatic arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma (HCC) associated with hypersplenism. Five patients suffering from primary HCC associated with hypersplenism caused by cirrhosis were received MWA combined with TACE. Follow-up examinations included calculation of peripheral blood cells (leukocytes, platelets and red blood cells) and treatment-associated complications. After treatment, leukocyte and platelet counts were significantly higher (P < 0.05) than prior-treatment. Right upper quadrant pain occurred in 3 patients, fever occurred in 4 patients, and mild nausea & vomiting occurred in 3 patients. Complications such as pleural effusion, ascites, bacterial peritonitis, and variceal bleeding did not occur after treatment. So, MWA combined with TACE is effective and safe for the patients with HCC associated with hypersplenism caused by cirrhosis.

Keywords

Efficacy, Safety, MWA, TACE, HCC, Hypersplenism

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. The Lancet, 362, 1907-1917. http://dx.doi.org/10.1016/S0140-6736(03)14964-1
[2]	Bruix, J., Sala, M. and Llovet, J.M. (2004) Chemoembolization for Hepatocellular Carcinoma. Gastroenterology, 127, S179-S188. http://dx.doi.org/10.1053/j.gastro.2004.09.032
[3]	Han, M.J., Zhao, H.G., Ren, K., et al. (1997) Partial Splenic Embolization for Hypersplenism Concomitant with or after Arterial Embolization of Hepatocellular Carcinoma in 30 Patients. CardioVascular and Interventional Radiology, 20, 125-127. http://dx.doi.org/10.1007/s002709900119
[4]	Ohmoto, K. and Yamamoto, S. (2003) Prevention of Variceal Recurrence, Bleeding, and Death in Cirrhosis Patients with Hypersplenism, Especially Those with Severe Thrombocytopenia. Hepatogastroenterology, 50, 1766-1769.
[5]	Huang, J.H., Gao, F., Gu, Y.K., et al. (2007) Combined Treatment of Hepatocellular Carcinoma with Partial Splenic Embolization and Transcatheter Hepatic Arterial Chemoembolization. World Journal of Gastroenterology, 13, 6593-6597. http://dx.doi.org/10.3748/wjg.13.6593
[6]	Tajiri, T., Onda, M., Yoshida, H., et al. (2002) Long-Term Hematological and Biochemical Effects of Partial Splenic Embolization in Hepatic Cirrhosis. Hepatogastroenterology, 49, 1445-1448.
[7]	Kimura, F., Ito, H., Shimizu, H., Togawa, A., et al. (2003) Partial Splenic Embolization for the Treatment of Hereditary Spherocytosis. American Journal of Roentgenology, 181, 1021-1024. http://dx.doi.org/10.2214/ajr.181.4.1811021
[8]	Sakata, K., Hirai, K. and Tanikawa, K. (1996) A Long-Term Investigation of Transcatheter Splenic Arterial Embolization for Hypersplenism. Hepatogastroenterology, 43, 309-318.
[9]	Matsuoka, T., Yamamoto, A., Okuma, T., et al. (2007) CT-Guided Percutaneous Radiofrequency Ablation of Spleen: A Preliminary Study. American Journal of Roentgenology, 188, 1044-1046. http://dx.doi.org/10.2214/AJR.06.0641
[10]	Liang, P., Gao, Y., Zhang, H., et al. (2011) Microwave Ablation in the Spleen for Treatment of Secondary Hypersplenism: A Preliminary Study. American Journal of Roentgenology, 196, 692-696. http://dx.doi.org/10.2214/AJR.10.4193
[11]	Gao, F., Gu, Y.K., Shen, J.X., et al. (2011) Experimental Study of Destruction to Porcine Spleen in Vivo by Microwave Ablation. World Journal of Gastroenterology, 17, 5014-5020. http://dx.doi.org/10.3748/wjg.v17.i45.5014
[12]	Gao, Y., Wang, Y., Duan, Y., et al. (2010) 915MHz Microwave Ablation with High Output Power in in Vivo Porcine Spleens. European Journal of Radiology, 75, 87-90. http://dx.doi.org/10.1016/j.ejrad.2009.03.009
[13]	Roversi, R., Ricci, S., Gambari, P.I., et al. (1993) [Splenic Embolization and Hepatic Chemoembolization: Combined Transcatheter Treatment of Hepatocellular Carcinoma in Cirrhosis with Hypersplenism]. La Radiologia Medica, 85, 444-449.
[14]	Koconis, K.G., Singh, H. and Soares, G. (2007) Partial Splenic Embolization in the Treatment of Patients with Portal Hypertension: A Review of the English Language Literature. Journal of Vascular and Interventional Radiology, 18, 463-481. http://dx.doi.org/10.1016/j.jvir.2006.12.734
[15]	Shimizu, T., Onda, M., Tajiri, T., et al. (2002) Bleeding Portal-Hypertensive Gastropathy Managed Successfully by Partial Splenic Embolization. Hepatogastroenterology, 49, 947-949.
[16]	Romano, M., Giojelli, A., Capuano, G., et al. (2004) Partial Splenic Embolization in Patients with Idiopathic Portal Hypertension. European Journal of Radiology, 49, 268-273. http://dx.doi.org/10.1016/S0720-048X(03)00134-7
[17]	Brace, C.L. (2009) Radiofrequency and Microwave Ablation of the Liver, lung, Kidney, and Bone: What Are the Differences? Current Problems in Diagnostic Radiology, 38, 135-143. http://dx.doi.org/10.1067/j.cpradiol.2007.10.001
[18]	Brace, C.L. (2009) Microwave Ablation Technology: What Every User Should Know. Current Problems in Diagnostic Radiology, 38, 61-67. http://dx.doi.org/10.1067/j.cpradiol.2007.08.011
[19]	Duan, Y.Q., Gao, Y.Y., Ni, X.X., et al. (2007) Changes in Peripheral Lymphocyte Subsets in Patients after Partial Microwave Ablation of the Spleen for Secondary Splenomegaly and Hypersplenism: A Preliminary Study. International Journal of Hyperthermia, 23, 467-472. http://dx.doi.org/10.1080/02656730701474533
[20]	Wang, H.Y., Shih, S.C., Lin, S.C., et al. (2008) Partial Splenic Embolization: 12-Month Hematological Effects and Complications. Hepatogastroenterology, 55, 1838-1842.
[21]	Liu, Q., Ma, K., He, Z., et al. (2005) Radiofrequency Ablation for Hypersplenism in Patients with Liver Cirrhosis: A Pilot Study. Journal of Gastrointestinal Surgery, 9, 648-657. http://dx.doi.org/10.1016/j.gassur.2004.11.006